Travis Dalton - 27 Feb 2026 Form 4 Insider Report for Claritev Corp (CTEV)

Role: Pres., CEO & Executive Chair, Director
Signature: /s/ Kent Bartholomew, attorney-in-fact
Issuer symbol: CTEV
Transactions as of: 27 Feb 2026
Net transactions value: +$199,928
Form type: 4
Filing time: 02 Mar 2026, 16:38:34 UTC
Previous filing: 20 Nov 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dalton Travis	Pres., CEO & Executive Chair, Director	C/O CLARITEV CORPORATION, 7900 TYSONS ONE PLACE, SUITE 400, MCLEAN	/s/ Kent Bartholomew, attorney-in-fact	02 Mar 2026	0001841409

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTEV	Class A common stock	Purchase	$199,928	+15,380	+161%	$13.00	24,952	27 Feb 2026	Spouse's Individual Retirement Account	F1
holding	CTEV	Class A common stock						243,058	27 Feb 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.940 to $13.000, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.940 to $13.000, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.